Health Care & Life Sciences » Pharmaceuticals | Botanix Pharmaceuticals Ltd.

Botanix Pharmaceuticals Ltd. | Balance Sheet

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
2,512.60
1,308.70
3,652.00
5,720.50
17,283.90
Total Accounts Receivable
29.50
11.80
38.00
162.50
426.60
Other Current Assets
11.20
-
6.70
24.40
-
Total Current Assets
2,553.40
1,320.60
3,696.70
5,907.40
17,710.50
Total Assets
2,553.40
1,320.60
3,696.70
5,907.40
17,710.50
Accounts Payable
309.80
33.40
456.20
453.60
1,425.60
Other Current Liabilities
-
58.20
59.60
17.00
-
Total Current Liabilities
309.80
91.60
515.80
470.60
1,425.60
Total Liabilities
309.80
91.60
515.80
470.60
1,425.60
Common Equity (Total)
2,243.50
1,229.00
3,180.90
5,436.80
16,284.90
Total Shareholders' Equity
2,243.50
1,229.00
3,180.90
5,436.80
16,284.90
Total Equity
2,243.50
1,229.00
3,180.90
5,436.80
16,284.90
Liabilities & Shareholders' Equity
2,553.40
1,320.60
3,696.70
5,907.40
17,710.50

About Botanix Pharmaceuticals

View Profile
Address
50 Angove Street
North Perth Western Australia (WA) 6006
Australia
Employees -
Website http://www.botanixpharma.com
Updated 07/08/2019
Botanix Pharmaceuticals Ltd. engages in the development of next generation therapeutics for the treatment of skin diseases. It focuses on the treatment of patients battling with acne, psoriasis, and atoptic dermatitis. The company also develops pharmaceutical ingredient known as cannabidol, which seeks to treat epilepsy, pain, arthritis, and schizophrenia.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.